IVF/Fertility company with leading clinical reputation and performance. Partnered with UK-based Nobel prize winning inventors of the procedure
Investment Rationale
Building a fast growing and profitable fertility/IVF business, based on a collaboration with one of the leading IVF companies in the world, Bourn Hall Clinic, UK: Clinical and Technology leadership combined with brand credibility and recognition meets unmet clinical demand.
| Investment date | July 2010 |
| Exit date | Partial exit 2018, Full exit November 2021– Read the Exit Announcement |
| Sector | IVF, Assisted Reproduction |
| Region | UAE |
| Investment type | Greenfield |
Business Highlights and Impact
- Conceptualized the UAE business in 2010 with the management of Bourn Hall Clinic, UK, to provide quality access to IVF/Fertilty services in the UAE
- Business plan creation and syndicated financing for the business in 2010
- Applied ESG Framework
- In late 2018, Mediclinic Middle East bought a 30% stake and provided increased market access
- Structured transaction with Mediclinic in late 2018 which resulted in expansion and growth across the UAE
- Entering the year 2021, the company in 2021 was a leader in clinical performance in the UAE, full exit in November 2021